<\/p>\n\n\n\n
January 31, 2024<\/p>\n\n\n\n
DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring (TDM) and creators of DoseMeRx and DoseMe Analytics<\/a>, today announced the appointment of Siegfried\u00a0Braeuer\u00a0to Director, International Sales. In this role, he will lead the expansion of DoseMe\u2019s Model Informed Precision Dosing (MIPD) platform through channel partners and direct sales across multiple continents.<\/p>\n\n\n\n Siegfried Braeuer brings a wealth of experience in pharma with a long tenure at Merck. Additional roles at Swiss Alpinopharma, Amarin GmbH, Interim Management\/Consulting and Canpharma, added to Siegfried \u2018Sigi\u2019 vast experience building teams across the emerging markets of the Eastern Europe, Middle East, and Africa region.\u00a0Braeuer, an alumnus of\u00a0Johannes Kepler University Linz and the MBA program at Emory University, joins DoseMe with more than 20 years of experience leading high-performance teams across pharmaceutical, commercialization and technology spanning multiple geographies including\u00a0US, UK, Brazil and India.<\/p>\n\n\n\n “The healthcare industry is on a digital transformation journey and EMEA, MEA, Latin America and Asia are fast growing markets with the adoption of precision medicine on an upward trajectory,” said Paul Edwards, CEO of DoseMe. “I am confident that Sigi has the knowledge, skills, proven experience and passion to drive our vision forward and continue to make DoseMe the preferred choice for healthcare organizations.\u201d<\/p>\n\n\n\n In the past year, the company has expanded its distribution network with exclusive resellers across 29 countries.\u00a0<\/strong>DoseMe continues to focus on\u00a0product innovation and go-to-market expansion\u00a0to build\u00a0new drug models<\/a>\u00a0to broaden the MTDM platform. Under Braeuer’s leadership, diversifying the channels and adding new partners will enable the company to offer a wide range of AI-powered systems for real-time patient care.<\/p>\n\n\n\n “DoseMe is at an inflection point as the advent of AI in precision dosing takes shape and is driving the increasing demand around the globe. I am excited to work with these exceptionally talented individuals to achieve our next phase of growth,\u201d\u00a0said Braeuer.<\/p>\n\n\n\n <\/p>\n\n\n\n About DoseMe<\/strong>: Media Contact:<\/strong> Scopri quanto \u00e8 facile usare e integrare DoseMeRx nel tuo lavoro quotidiano.<\/p>\n Richiedi una dimostrazione di prova qui sotto. Puoi anche chiamarci al numero +1 (832) 358-3308<\/a>\u00a0oppure scriverci all\u2019indirizzo\u00a0hello@dosemehealth.com<\/a><\/p>\n<\/div>\t\t\r\n\r\n
DoseMe combines smart technology with science, leveraging clinically-validated PK\/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https:\/\/doseme-rx.com\/success-stories<\/a>.<\/p>\n\n\n\n
Alison Guzzio
aburnsguzzio@gmail.com
484-459-3243<\/p>\n\n\nRichiedi una dimostrazione di prova<\/h2>\r\n\t